Lv7
4020 积分 2021-05-25 加入
Advancing target validation with PROTAC technology
5天前
已完结
Development of an ELISA with acidification treatment for an antibody conjugate incorporating Exatecans
21天前
已完结
Strategies for Precise Modulation of Protein Degradation
24天前
已完结
Probing the E3 Ligase Adapter Cereblon with Chemical Biology
24天前
已完结
Trends in the drug target landscape for autoimmune diseases
24天前
已完结
Tracking E2-specific substrates
24天前
已关闭
Implications of frequent hitter E3 ligases in targeted protein degradation screens
24天前
已完结
METTL3-mediated m6A modification of PAK6 drives cervical cancer progression through activating MAPK14
25天前
已关闭
Structural insights, regulation, and recent advances of RAS inhibitors in the MAPK signaling cascade: a medicinal chemistry perspective
29天前
已完结
Patent landscape of small molecule inhibitors of METTL3 (2020-present)
1个月前
已完结
Systematic review of vismodegib toxicity profile in the treatment of advanced basal cell carcinomas compared to other systemic therapies in dermatology
皖公网安备34019202002308
